Featured
We asked Marty Cooper for his perspective on how Chicago had sustained its telecommunications cluster for so long.
Patrick Coughlin visits “This Week With CalCISO” to discuss industry maturation, integration, and the potential for security to evolve with metrics and measurement.
In this week's episode of CTC's Artificial Intelligence Series with Foley and Lardner, we speak with machine learning and data science advisor Beau Norgeot, an advisor to startup Lucid Lane
This Week With CalCISO, Paul Kurtz joins us to discuss the data-centric security model.
This is the first in a podcast series featuring CompTIA leaders and their children discussing their generational views of emerging technologies.
Amanda meets with Estelle Johannes, director of the UK Business Technology Community at CompTIA, to discuss the challenges, struggles, and opportunities of being a female business owner in the tech industry.
The Bio Report spoke to Bill Hagstrom, CEO of Octave, about the company’s efforts to harness novel measurements of disease to individualize care, the case it’s making with payers, and why the company is starting with MS.
Dr. Jonathan Javitt from NeuroRX Pharma talks about a scientific discovery which lingered for nearly two decades in some 70 boxes in deep storage – it’s now being tested as a treatment for COVID-19.
The Bio Report spoke to Matthew Price, co-founder, executive vice president, and chief operating officer of Phosplatin, about the company’s lead therapy, its multiple mechanisms of action, and why it may have benefit in a broad range of cancers.
Jonah Berger discusses his latest book on influence.
The Bio Report spoke to Leo Grady, CEO of Paige, about how the company’s artificial intelligence platform works, why it may lead to the identification of new biomarkers, and the potential for AI to change the way cancer patients are diagnosed.
On this week’s Tech Nation, Moira speaks with Dr. Greg Frost, the CEO of Exuma Biotech. He explains gene therapy for cancer.
The Bio Report spoke to Farlan Veraitch, co-founder and chief scientific officer of Ori, about the challenges of manufacturing cell and gene therapies, how the company’s platform addresses those issues, and why it is initially focusing on CAR-T cell therapies.
On this week’s Tech Nation, Moira speaks with Neuroscientist Daniel Levitin about his book “Successful Aging … A Neuroscientist Explores the Power and Potential of Our Lives”.
The Bio Report spoke to Shlomi Raz, CEO of Eleusis, about of the case for psychedelics as treatments for inflammatory conditions, how they work, and what challenges the development of these drugs pose.
Sarah Frier talks about her book on the story of Instagram.
The Bio Report this week speaks to Jeff Bluestone, CEO of Sonoma, about regulatory T cell therapies
In this week's episode of CTC's Artificial Intelligence Series with Foley and Lardner, we talk with Berkeley Professor Bin Yu on the ways machine learning and AI are being applied to assist the COVID effort.
This week, the Bio Report speaks to Jeff Fischer, president of Longhorn, about the benefits of the company’s technology for gathering and transporting diagnostic samples, how it’s used partnerships to scales it business with speed, and why the pandemic has forever changed the company.